On June 24, 2019 Supreme Cannabis (FIRE.T) announced the launch of Supreme Heights, an investment platform based in London, UK “focused on opportunities in the UK and Europe’s CBD health and wellness space.”

Supreme Cannabis’ portfolio includes the kick-ass brand 7ACRES, plant genetics co. Cambium Plant Sciences, oil producer Medigrow Lesotho and a licensing deal with Khalifa Kush Enterprises Canada.

“The growth of the CBD and cannabis markets have been slower than they have been in the United States in part because in the EU, CBD is largely limited to topical use and tobacco products,” stated The Rolling Stone on March 26, 2019, “while its use in ingestibles (such as food additives, tinctures and capsules) is prohibited.”

That may change, however, following an amendment proposed by the European Food Safety Agency to allow CBD in ingestible products, which could pass at the end of the year.

International business based in the UK are currently in a state of flux, as they prep for “a no-deal Brexit” amid signs that the UK’s next Prime minister could be prepared to leave the EU without a deal at the end of October.

Despite this uncertainty, investing in the European CBD market is something most investors will instantly applaud.

But it isn’t intuitively obvious why Supreme needed to create a separate entity to do this.

This morning, we gave Supreme a call.  The company explained that the structure and governance of Supreme Heights creates significant “flexibility and creativity” in the way that European investments are made.

The European Union is one of the world’s largest and most sophisticated markets, with member countries adhering to a galaxy of different rules and regulations.

“Supreme Heights intends to make strategic investments in and provide support services to differentiated high-growth health and wellness businesses with focused brands and premium CBD offerings.”

Supreme Heights will piggy-back on FIRE’s “regulatory, product commercialization, supply chain, marketing and capital markets expertise and corporate support services”, while drawing on FIRE’s experience launching premium brands.

“The rapidly evolving CBD markets in the UK and Europe present compelling investment opportunities,” stated Navdeep Dhaliwal, CEO of Supreme, “We look forward to driving value for Supreme Cannabis shareholders through this investment platform.”

Patrick Morton will serve as CEO of Supreme Heights. As co-founder of Cannabis Invest UK – Morton is wired into the European cannabis ecosystem. He has a network of local and global cannabis and CBD companies on speed dial and relationships with the UK and Europe’s institutional and high net worth investors.

The rest of Supreme Heights’ Board and Management Team:

Navdeep Dhaliwal, Chairman – CEO of Supreme Cannabis; former Principal of NLX Capital Corp, a Canadian merchant bank.

Nick Davis, Director – CEO of Memery Crystal, one of the UK’s leading law firms; specializes in flotations, equity capital markets and mergers & acquisitions.

Scott Walters, Director – VP of Corp. Dev. at Supreme Cannabis. Former CEO of Molecular Science Corporation.

Riyaz Lalani, Director – Chief Corporate Officer of Supreme; formerly with Bayfield Strategy – communications and stakeholder relations firm.

Supreme’s collaboration with Khalifa Kush Enterprises demonstrates that it can grow good product.

Wiz Khalifa (born Cameron Jibril Thomaz) is a 31-year-old ex-military brat who lived in Germany, the U.K, and Japan before settling in Pittsburgh with his mother.

He released his debut album, Show and Prove, at the age of 19  The debut single for Atlantic, “Black and Yellow” peaked at number one on the Billboard Hot 100.

 “Khalifa Kush is a hybrid that was bred specifically for the rap artist Wiz Khalifa,” confirms Leafly.com, “it has an active cerebral buzz ideal for morning and daytime use.”

Wiz’s strain has 572 reviews on Leafly – with a 4.7 average rating.

“Dear Khalifa Kush, I am writing this to inform you that I am stoned,” states Senatorbear. “Stoned in a happy way, a loving way. For some odd reason, this strain is my new Viagra.”

“This strain had to be the best upper I have gotten for anything i have smoked,” states Kingjman, “Not only do i have love for the Rapper (Wiz Khalifa), but now know why he’s so happy always and jumping around.”

While farming and branding remain at the company’s core, FIRE is also looking outward at new markets, new biz opportunities.

“Supreme cleared the final hurdles with Health Canada to make marijuana extracts a reality north of the border,” stated Equity Guru’s Sam Bourgi last week, “Setting the stage for a major production boost in a sub-industry worth billions.

In a Tuesday press release, Supreme said it was on track to meet Health Canada’s amended cannabis regulations for edibles, extracts and topicals. The new regulations are aligned with Supreme’s product strategy and will allow the company to enter the high-profile extracts market in the near future.

“We intend to make targeted investments in wellness brands that provide exposure to value-add categories in the UK and Europe’s CBD market,” stated the CEO of Supreme Heights, Patrick Morton, “including vaporizers, edibles and beverages, topicals and ancillary services.”

“CBD is just starting to take hold in Europe, with both product availability and consumer awareness still quite limited,” stated Bethany Gomez, Managing Director of Brightfield, “This is a great opportunity for developed brands to enter and expand through Europe with far less competition than we’re seeing in the U.S.”

Full Disclosure: Supreme Cannabis is an Equity Guru marketing client, and we own the stock.